For example, genes regulating Wnt, KRAS/ MAPK, PI3K, TGF-β, and NF-κB pathways are frequently reported to be mutated or inactivated in human cancer (De Rosa et al., 2016; Hanahan & Weinberg, 2011; Sharma, Kelly & Jones, 2009). This evidence concerns the gene NFKB1 and cancer.